Behavioural evaluation of cholinergic drugs.
Alzheimer's disease involves progressive degeneration of the cortex and the limbic system. Loss of afferent forebrain neurochemical modulatory systems is also seen, most significantly of the basal forebrain cholinergic system. Drug discovery programmes have pursued enhancement of forebrain musc...
| Main Author: | |
|---|---|
| Format: | Conference item |
| Published: |
1997
|